1. GaN‐on‐silicon high electron mobility transistors with blocking voltage of 3 kV. Issue 19 (4th September 2015) Authors: Herbecq, N.; Roch‐Jeune, I.; Linge, A.; Grimbert, B.; Zegaoui, M.; Medjdoub, F. Journal: Electronics letters Issue: Volume 51:Issue 19(2015) Page Start: 1532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High PAE high reliability AlN/GaN double heterostructure. (November 2015) Authors: Medjdoub, F.; Zegaoui, M.; Linge, A.; Grimbert, B.; Silvestri, R.; Meneghini, M.; Meneghesso, G.; Zanoni, E. Journal: Solid-state electronics Issue: Volume 113(2015) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group. (July 2019) Authors: Eder, T.; Hess, A.K.; Konschak, R.; Stromberger, C.; Jöhrens, K.; Fleischer, V.; Hummel, M.; Balermpas, P.; von der Grün, J.; Linge, A.; Lohaus, F.; Krause, M.; Baumann, M.; Stuschke, M.; Zips, D.; Grosu, A.L.; Abdollahi, A.; Debus, J.; Belka, C.; Pigorsch, S. Journal: European journal of cancer Issue: Volume 116(2019) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MO-0139 PORT-C improves LRC in a subset of patients with intermediate-risk HNSCC: A matched pair analysis. (May 2022) Authors: Patil, S.; Linge, A.; Hiepe, H.; Grosser, M.; Lohaus, F.; Gudziol, V.; Nowak, A.; Tinhofer, I.; Budach, V.; Guberina, M.; Stuschke, M.; Balermpas, P.; Rödel, C.; Schäfer, H.; Grosu, A.; Abdollahi, A.; Debus, J.; Belka, C.; Pigorsch, S.; Combs, S.E. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0062 Potential predictive biomarkers for Nimorazole-modified radiochemotherapy in head and neck cancer. (August 2021) Authors: Besso, M.J.; Bitto, V.; Koi, L.; Hadiwikarta, W.; Euler-Lange, R.; Bonrouhi, M.; Linge, A.; Krause, M.; Kurth, I.; Baumann, M. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC-0152: Glutamine metabolism as potential biomarker and target for prostate cancer radiosensitization. (April 2018) Authors: Dubrovska, A.; Tyutyunnykova, A.; Chen, O.; Linge, A.; Löck, S.; Telychko, V.; Richter, S.; Hein, L.; Toma, M.; Zschaeck, S.; Eisenhofer, G.; Wirth, M.; Kunz-Schughart, L.; Tawk, B.; Schwager, C.; Abdollahi, A.; Baretton, G.; Krause, M.; Baumann, M. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC-0256 Biomarker development from joint analyses of HNSCC xenografts and patients treated by PORT-C. (May 2022) Authors: Linge, A.; Patil, S.; Gurtner, K.; Grosser, M.; Lohaus, F.; Gudziol, V.; Nowak, A.; Tinhofer, I.; Budach, V.; Guberina, M.; Stuschke, M.; Balermpas, P.; Rödel, C.; Schäfer, H.; Grosu, A.; Abdollahi, A.; Debus, J.; Belka, C.; Pigorsch, S.; Combs, S.E. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC-0269: Comparison of tumour hypoxia measured by FMISO-PET and gene signatures for patients with HNSCC. (April 2018) Authors: Löck, S.; Linge, A.; Seidlitz, A.; Bandurska-Luque, A.; Großer, M.; Baretton, G.; Zöphel, K.; Zips, D.; Troost, E.; Krause, M.; Baumann, M. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC-0276: Combining different genomic signatures to improve the prognostic power for LRC after PORT-C in HNSCC. (April 2018) Authors: Schmidt, S.; Linge, A.; Zwanenburg, A.; Leger, S.; Großer, M.; Lohaus, F.; Gudziol, V.; Nowak, A.; Tinhofer, I.; Budach, V.; Stuschke, M.; Balermpas, P.; Rödel, C.; Grosu, A.L.; Abdollahi, A.; Debus, J.; Belka, C.; Combs, S.E.; Mönnich, D.; Zips, D. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC-0277 A 6-gene signature for loco-regional control prognosis in HNSCC patients treated by PORT-C. (August 2021) Authors: Patil, S.; Linge, A.; Grosser, M.; Gudziol, V.; Nowak, A.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Schäfer, H.; Grosu, A.; Abdollahi, A.; Debus, J.; Ganswindt, U.; Belka, C.; Pigorsch, S.; Combs, S.E.; Mönnich, D. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗